Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized patients. The company currently has … [Read more...]
NEWS
Testing Guidelines at a Glance
September 12, 2017
The American Society of Clinical Oncology (ASCO) published updated practice guidelines Aug. 14 in the Journal of Clinical Oncology regarding the use of targeted immunotherapy for patients with stage … [Read more...]
NEWS
Inside the Diagnostics Industry: At-Home Testing Options Expanding
August 17, 2017
There is a proliferation of companies offering at-home testing. In some cases these are mail-in tests where patients collect their own samples (blood, mouth swab, urine, or stool) and mail them into a … [Read more...]
INDUSTRY TRENDS
Genomic Testing May Be Currently Overhyped, Oncologists Say
June 14, 2017
Most oncologists believe genomic testing is a major advance, but that it is "significantly overpromoted," according to a survey conducted by Medscape and the Swedish Cancer Institute in … [Read more...]
GENETIC TESTING
Genome Medical Bridges Genomic Testing, Medical Practice
May 16, 2017
Lisa Alderson, co-founder and CEO, Genome Medical Many well-known barriers are slowing the integration of genomic testing into routine clinical practice, including workforce shortages and a lack … [Read more...]
RESEARCH
iSpecimen Generates New Market for Discarded Biospecimens
May 2, 2017
iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such … [Read more...]
RESEARCH
iSpecimen Creates Marketplace for Clinical Discards
February 27, 2017
iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such … [Read more...]
PRECISION MEDICINE
Guidelines Suggest Standardized Interpretation and Reporting of Somatic Sequence Variants
January 23, 2017
A common refrain within the diagnostics industry is a need for standardization. Rapidly developing technology and testing methods, the call for interoperability, and the vast amount of data and … [Read more...]
REIMBURSEMENT
Inside The Diagnostics Industry: Medicare Coverage of Molecular Tests Continues to Evolve
January 18, 2017
Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for payors as far as coverage is concerned. Normally … [Read more...]
PRECISION MEDICINE
New Guidelines Suggest Tiered Approach to Standardize Interpretation and Reporting of Sequence Variants in Cancer
December 28, 2016
Aconstant refrain within the diagnostics industry is a need for standardization. Rapidly developing technology and testing methods, the call for interoperability, and the vast amount of data and … [Read more...]
